Citations

Clear

9383 citation(s) found for "Thomas, PS".

Increasing Prevalence and Associated Risk Factors for Methicillin Resistant Staphylococcus Aureus Bacteriuria
Routh, Jonathan C. , Alt, Angela L., Ashley, Richard , Kramer, Stephen A., Boyce, Thomas G. , Routh, Jonathan C

Mayo Clinic

Journal of Urology | February 24, 2009 | Volume: 181 | Issue: 4 | Pages: 1694-1698

10.1016/j.juro.2008.11.108 | PMID 19233426 Get It

Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth
Marlow, Laura A. , Cleland, Alan S., Kurakata, Shinichi, Fujiwara, Kôsaku, Zhang, Ying , Sebo, Thomas, Grant, Clive S., McIver, Bryan, Wadsworth, J. Trad , Smallridge, Robert C., Copland, John A. , Reynolds, Lisa A. , Cooper, Simon JR , Gumz, Michelle L. , Radisky, Derek C. , Marlow, Laura

Mayo Clinic

Cancer Research | February 11, 2009 | Volume: 69 | Issue: 4 | Pages: 1536-1544

10.1158/0008-5472.can-08-3718 | PMID 19208833 Get It

Abstract Anaplastic thyroid carcinoma (ATC) is a highly aggressive form of the disease for which new therapeutic options are desperately needed. Previously, we showed that the high-affinity peroxisome proliferator–activated receptor γ (PPARγ) agonist, RS5444, inhibits cell proliferation of ATC cells via induction of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 (p21). We show here that up-regulation of RhoB is a critical step in PPARγ-mediated activation of p21-induced cell stasis. Using multiple independently derived ATC cell lines, we found that treatment with RS5444 leads to the up-regulation of RhoB and subsequent activation of p21, and that silencing of RhoB by RNAi blocks the ability of RS5444 to induce p21 and to inhibit cell proliferation. Our results show that transcriptional regulation of RhoB by the nuclear transcription factor PPARγ is responsible for the induction of p21 mRNA and protein. We further implicate RhoB as a key signaling effector for the growth inhibition of ATC, as treatment with a histone deacetylase inhibitor shown to increase RhoB expression in lung cancer cells caused the up-regulation of RhoB in ATC cells accompanied by increased expression of p21 and inhibition of cell proliferation; this effect occurred even in ATC cells that were unresponsive to RS5444 due to a lack of expression of PPARγ. Our results implicate RhoB as a novel intermediate in critical signaling pathways and as an additional target for therapeutic intervention in ATC. [Cancer Res 2009;69(4):1536–44]
Pediatric Body CT, 2nd ed.
Thomas, Kristen B.

Mayo Clinic

American Journal of Roentgenology | January 20, 2009 | Volume: 192 | Issue: 2 | Pages: W83-W83

10.2214/ajr.08.1748 Get It

US Intergroup Anal Carcinoma Trial: Tumor Diameter Predicts for Colostomy
Winter, Kathryn, Gunderson, Leonard L., Pedersen, John, Benson, Al B. , Thomas, Charles R., Haddock, Michael G. , Rich, Tyvin A. , Willett, Christopher G. , Ajani, Jaffer A. , Mayer, Robert J.

Mayo Clinic

Journal of Clinical Oncology | January 13, 2009 | Volume: 27 | Issue: 7 | Pages: 1116-1121

10.1200/jco.2008.19.6857 | PMID 19139424 Get It

Purpose The US Gastrointestinal Intergroup Radiation Therapy Oncology Group 98-11 anal carcinoma trial showed that cisplatin-based concurrent chemoradiotherapy resulted in a significantly higher rate of colostomy compared with mitomycin-based therapy. Established prognostic variables for patients with anal carcinoma include tumor diameter, clinical nodal status, and sex, but pretreatment variables that would predict the likelihood of colostomy are unknown. Methods A secondary analysis was performed by combining patients in the two treatment arms to evaluate whether new predictive and prognostic variables would emerge. Univariate and multivariate analyses were carried out to correlate overall survival (OS), disease-free survival, and time to colostomy (TTC) with pretreatment and treatment variables. Results Of 682 patients enrolled, 644 patients were assessable and analyzed. In the multivariate analysis, tumor-related prognosticators for poorer OS included node-positive cancer (P ≤ .0001), large (> 5 cm) tumor diameter (P = .01), and male sex (P = .016). In the treatment-related categories, cisplatin-based therapy was statistically significantly associated with a higher rate of colostomy (P = .03) than was mitomycin-based therapy. In the pretreatment variables category, only large tumor diameter independently predicted for TTC (P = .008). Similarly, the cumulative 5-year colostomy rate was statistically significantly higher for large tumor diameter than for small tumor diameter (Gray's test; P = .0074). Clinical nodal status and sex were not predictive of TTC. Conclusion The combined analysis of the two arms of RTOG 98-11, representing the largest prospective database, reveals that tumor diameter (irrespective of the nodal status) is the only independent pretreatment variable that predicts TTC and 5-year colostomy rate in patients with anal carcinoma.
Single Myosin Lever Arm Orientation in a Muscle Fiber Detected with Photoactivatable GFP
Ajtai, Katalin , Burghardt, Thomas P. , Li, Jinhui

Mayo Clinic

Biochemistry | January 7, 2009 | Volume: 48 | Issue: 4 | Pages: 754-765

10.1021/bi8017703 | PMID 19127992 Get It

Sampling Strategies for Tissue Microarrays to Evaluate Biomarkers in Ovarian Cancer
Permuth‐Wey, Jenny, Boulware, David, Valkov, Nikola, Livingston, Sandra, Nicosia, Santo V., Lee, Ji‐Hyun , Sutphen, Rebecca , Schildkraut, Joellen M. , Narod, Steven A. , Parker, Alex , Coppola, Domenico , Sellers, Thomas A. , Pal, Tuya

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | January 5, 2009 | Volume: 18 | Issue: 1 | Pages: 28-34

10.1158/1055-9965.epi-08-0713 | PMID 19124477 Get It

Abstract Introduction: Tissue microarrays (TMA) enable rapid analysis of biomarkers in large-scale studies involving archival tumor specimens, however, their utility in heterogeneous tumors such as ovarian cancer is limited. Methods: In this study, immunohistochemical analysis was done on TMAs comprised of epithelial ovarian cancer (EOC) to estimate the prevalence of loss of expression of three mismatch repair proteins. TMAs were initially created using cores sampled from the center of donor tissue blocks from 59 EOC cases. Full sections were subsequently created and levels of expression were compared between tissues sampled from the central portion versus the periphery. Follow-up analyses were done by obtaining cores from the periphery of up to five additional donor blocks per case. A linear mixed model for each protein was used to investigate differences between results from the initial and follow-up blocks. Results: In the original TMAs created using centrally sampled cores, loss of mismatch repair expression was noted in 17 (29%) of the 59 cases. By comparison, analyses from peripherally sampled cores revealed loss of expression in only 6 of these 17 cases. For each protein, significant differences (P < 0.05) were detected between results from the initial donor block and the majority of the follow-up blocks. Conclusions: Our investigations, based on EOC, suggest that sampling variability in protein expression may result when TMAs are used. Thus, at least for EOC, it is important to preferentially sample from the periphery of tumor blocks where exposure to tissue fixatives is optimal. (Cancer Epidemiol Biomarkers Prev 2009;18(1):28–34)
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
Roher, Alex E., Esh, Chera L., Kokjohn, Tyler A., Castaño, Eduardo M., Vickle, Gregory D. Van, Kalback, Walter M., Patton, Rebekah , Luehrs, Dean C., Daugs, Ian D., Kuo, Yu‐Min , Emmerling, Mark R., Soares, Holly , Quinn, Joseph F. , Kaye, Jeffrey , Connor, Donald J., Silverberg, Nina, Seward, James D., Beach, Thomas G. , Adler, Charles H. , Sabbagh, Marwan Noel , Quinn, Joseph F

Mayo Clinic

Alzheimer's & Dementia | December 31, 2008 | Volume: 5 | Issue: 1 | Pages: 18-29

10.1016/j.jalz.2008.10.004 | PMID 19118806 Get It

BackgroundWe evaluated the amounts of amyloid beta (Aβ)) peptides in the central nervous system (CNS) and in reservoirs outside the CNS and their potential impact on Aβ plasma levels and Alzheimer's disease (AD) pathology.MethodsAmyloid β levels were measured in (1) the plasma of AD and nondemented (ND) controls in a longitudinal study, (2) the plasma of a cohort of AD patients receiving a cholinesterase inhibitor, and (3) the skeletal muscle, liver, aorta, platelets, leptomeningeal arteries, and in gray and white matter of AD and ND control subjects.ResultsPlasma Aβ levels fluctuated over time and among individuals, suggesting continuous contributions from brain and peripheral tissues and associations with reactive circulating proteins. Arteries with atherosclerosis had larger amounts of Aβ40 than disease‐free vessels. Inactivated platelets contained more Aβ peptides than activated ones. Substantially more Aβ was present in liver samples from ND patients. Overall, AD brain and skeletal muscle contained increased levels of Aβ.ConclusionsEfforts to use plasma levels of Aβ peptides as AD biomarkers or disease‐staging scales have failed. Peripheral tissues might contribute to both the circulating amyloid pool and AD pathology within the brain and its vasculature. The wide spread of plasma Aβ values is also due in part to the ability of Aβ to bind to a variety of plasma and membrane proteins. Sources outside the CNS must be accounted for because pharmacologic interventions to reduce cerebral amyloid are assessed by monitoring Aβ plasma levels. Furthermore, the long‐range impact of Aβ immunotherapy on peripheral Aβ sources should also be considered.
The Impact of Discordance Between Biopsy and Pathological Gleason Scores on Survival After Radical Prostatectomy
Boorjian, Stephen A. , Karnes, R. Jeffrey , Crispen, Paul L. , Rangel, Laureano J. , Bergstralh, Eric J., Sebo, Thomas J., Blute, Michael L.

Mayo Clinic

Journal of Urology | December 17, 2008 | Volume: 181 | Issue: 1 | Pages: 95-104

10.1016/j.juro.2008.09.016 | PMID 19012937 Get It

Outcomes Following Partial Nephrectomy by Tumor Size
Crispen, Paul L. , Boorjian, Stephen A. , Lohse, Christine M. , Sebo, Thomas S., Cheville, John C. , Blute, Michael L., Leibovich, Bradley C.

Mayo Clinic

Journal of Urology | December 17, 2008 | Volume: 180 | Issue: 5 | Pages: 1912-1917

10.1016/j.juro.2008.07.047 | PMID 18801543 Get It

Superficial Genitourinary Abscesses in Children: Emergence of Methicillin Resistant Staphylococcus Aureus
Alt, Angela L., Routh, Jonathan C. , Ashley, Richard , Boyce, Thomas G. , Kramer, Stephen A., Routh, Jonathan C

Mayo Clinic

Journal of Urology | December 17, 2008 | Volume: 180 | Issue: 4 | Pages: 1472-1475

10.1016/j.juro.2008.06.055 | PMID 18710758 Get It